Trial
NCT02143804
Safety and Efficacy of CG0070 Oncolytic Virus Regimen in Patients With High Grade Non-Muscle Invasive Bladder Cancer
Phase IIWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
CG Oncology, Inc.
Collaborators
—
Condition
Bladder Cancer
Intervention
oncolytic adenovirus expressing GMCSF
Why stopped
Change in trial design
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-04-02